<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04535219</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201901937</org_study_id>
    <nct_id>NCT04535219</nct_id>
  </id_info>
  <brief_title>Effect of Total Sleep Deprivation on Vascular Function</brief_title>
  <official_title>Effect of Total Sleep Deprivation on Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insufficient sleep is associated with an increased risk for cardiovascular disease. The&#xD;
      causal mechanisms are currently unknown, but may include endothelial dysfunction. The purpose&#xD;
      of this study is to examine the influence of sex and aging on the effects of total sleep&#xD;
      deprivation on vascular function and whether exercise training attenuates these effects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>through study completion, an average of 1 month</time_frame>
    <description>Endothelial function will be determined using brachial artery flow-mediated dilation via high resolution duplex ultrasonography. Reactive hyperemia will be produced by inflating a forearm cuff to ~250 mmHg for 5 minutes followed by rapid deflation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microvascular function</measure>
    <time_frame>through study completion, an average of 1 month</time_frame>
    <description>Microvascular function will be assessed using the forearm blood flow response to submaximal handgrip exercise. Brachial artery blood flow and diameter will be assessed using Doppler ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central arterial stiffness</measure>
    <time_frame>through study completion, an average of 1 month</time_frame>
    <description>The SphygmoCor XCEL device will be used to measure carotid to femoral pulse wave velocity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central arterial hemodynamics</measure>
    <time_frame>through study completion, an average of 1 month</time_frame>
    <description>The SphygmoCor XCEL device will be used to obtain central pulse wave analysis.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Sleep Deprivation</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have vascular function assessed following total sleep deprivation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will have vascular function assessed following a full night of sleep</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have vascular function assessed following total sleep deprivation preceded by exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will have vascular function assessed following a full night of sleep</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>60 minutes of moderate-intensity treadmill exercise (70% of maximal heart rate determined from the maximal graded exercise test)</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supervised Total Sleep Deprivation</intervention_name>
    <description>Laboratory-monitored total sleep deprivation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Males and females&#xD;
&#xD;
          -  20 to 30 and 50 to 60 years of age&#xD;
&#xD;
          -  Females will be eumenorrheic at enrollment or postmenopausal for at least 1 year&#xD;
&#xD;
          -  No major clinical disease (e.g., diabetes, cardiovascular, liver or chronic kidney&#xD;
             disease) to minimize confounding of vascular measures&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Age &lt;20 or 31 to 49 or &gt;60 years&#xD;
&#xD;
          -  Body mass index â‰¥30 kg/m^2 because obesity may affect vascular function&#xD;
&#xD;
          -  Use of medication that may affect vascular measures&#xD;
&#xD;
          -  Hormone replacement therapy or hormonal contraceptives within past year&#xD;
&#xD;
          -  Use of tobacco products (chewing tobacco, traditional or e-cigarettes) because they&#xD;
             may influence vascular function&#xD;
&#xD;
          -  Being perimenopausal, pregnant or lactating because may influence vascular function&#xD;
&#xD;
          -  Being a shift worker because habitual sleep deprivation and altered circadian rhythm&#xD;
             may influence vascular function.&#xD;
&#xD;
          -  Not having an &quot;intermediate&quot; chronotype based on the Morningness-Eveningness&#xD;
             Questionnaire (MEQ; score &lt;31 or &gt;69) because this would influence the effect of&#xD;
             overnight sleep deprivation on vascular function.&#xD;
&#xD;
          -  Sleep complaints based on the Pittsburgh Sleep Quality Index (PSQI; score &gt;5) because&#xD;
             this would influence the effect of overnight sleep deprivation on vascular function.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Demetra Christou, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Demetra Christou, PhD</last_name>
    <phone>352-294-1746</phone>
    <email>ddchristou@ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brady Holmer</last_name>
    <email>ICPL@hhp.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Deprivation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

